CME (CME) stock
Financials · Financial Exchanges & Data
CME (CME) is a Financial Exchanges & Data company in the Financials sector, headquartered in Chicago, Illinois. As of October 23, 2026, CME closed at $305.71, a market capitalization of $109.42 billion, the 113th largest company in the S&P 500. Over the last twelve months it generated $6.96 billion in revenue (+13% year over year) and $4.21 billion in free cash flow. The stock trades at 25.1x trailing earnings and 23.1x forward earnings.
- 1-year total return: +18.1% (dividends reinvested)
- 5-year return: +11.6% a year
- 52-week range: $218.31 – $329.16
- Gross margin 100.0%, operating margin 65.9%
- Dividend yield: 1.70%, 15 straight years of increases
- FI Handbook report card: B- across 10 metrics
- 19th largest of 76 Financials stocks in the S&P 500
CME price chart
1Y price change: +13.7% (price only; total returns below include dividends)
| Total return | 1M | YTD | 1Y | 3Y | 5Y | 10Y | MAX |
|---|---|---|---|---|---|---|---|
| CME | +12.9% | +15.8% | +18.1% | +17.6% | +11.6% | +15.7% | +19.8% |
Dividends reinvested. 3Y and longer are annualized; MAX is annualized since 2002.
CME key statistics
- Market cap
- $109.4B
- #113 in S&P 500
- P/E (TTM)
- 25.1x
- Forward P/E
- 23.1x
- EPS (TTM)
- $12.20
- Revenue (TTM)
- $7.0B
- +13%
- Free cash flow
- $4.2B
- Gross margin
- 100.0%
- Operating margin
- 65.9%
- Return on equity
- 16.1%
- Dividend yield
- 1.70%
- 52-week range
- $218.31 – $329.16
- Beta
- 0.27
- Price / sales
- 15.7x
- EV / EBITDA
- 22.5x
- Debt / equity
- 0.15x
- Employees
- 3,875
CME report card
B-Ten fundamentals graded A to F against fixed thresholds. Not a buy or sell rating.
- Revenue growth13.0%B
- Gross margin100.0%A
- Operating margin65.9%A
- FCF margin60.6%A
- Return on equity16.1%B
- Net debt / EBITDA0.3xB
- Forward P/E23.1xC
- PEG ratio4.8xF
- Shareholder yield1.7%C
- Share count change / yr0.1%C
CME financials
Revenue went from $3.6B in fiscal 2016 to $6.5B in fiscal 2025, growing 6.8% a year.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.6B | $3.6B | $4.3B | $4.9B | $4.9B | $4.7B | $5.0B | $5.6B | $6.1B | $6.5B |
| Operating income | $2.2B | $2.3B | $2.6B | $2.6B | $2.6B | $2.6B | $3.0B | $3.4B | $3.9B | $4.2B |
| Net income | $1.5B | $4.1B | $2.0B | $2.1B | $2.1B | $2.6B | $2.7B | $3.2B | $3.5B | $4.1B |
| EPS (diluted) | $4.53 | $11.94 | $5.71 | $5.91 | $5.87 | $7.29 | $7.40 | $8.86 | $9.67 | $11.16 |
| Free cash flow | $1.6B | $1.7B | $2.3B | $2.4B | $2.5B | $2.3B | $3.0B | $3.4B | $3.6B | $4.2B |
| Dividends paid | $1.8B | $2.0B | $2.1B | $1.7B | $2.1B | $2.2B | $2.6B | $3.2B | $3.6B | $3.9B |
| Diluted shares | 339.0M | 340.2M | 343.7M | 358.2M | 358.5M | 358.9M | 359.2M | 359.5M | 359.9M | 360.3M |
Source: SEC filings (10-K XBRL). EPS and share counts are split-adjusted.
What's priced into CME?
A reverse DCF asks what growth the current price requires. With an enterprise value of $110.9B and $4.2B of trailing free cash flow, CME needs to grow free cash flow about 17.5% a year for ten years (fading to 3.0% terminal growth) to earn a 10% annual return. For context, free cash flow grew 10.7% a year over the last five years.
P/E ratio history
Current 27.4x vs. median 26.5x (10th–90th percentile 14.4x–33.8x).
A model, not a forecast or advice. Small changes in assumptions move the answer a lot.
CME dividend
- Dividend yield
- 1.70%
- Annual dividend
- $5.20
- Years of increases
- 15
- 5-yr dividend growth
- 8.0%
- per year
- Payout ratio
- 95%
- Payments per year
- 4
Regular dividends per share by calendar year; special dividends excluded. Current year omitted until complete.
CME analyst price targets
16 analysts' average 12-month target is $316.00 (+3% vs. $305.71). Targets range from $227.00 to $367.00. 53% rate it a buy.
CME earnings
Next report: February 3, 2027. CME has beaten EPS estimates 2 quarters in a row.
| Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|
| Oct 21, 2026 | $2.99 | $3.02 | +1.0% |
| Jul 22, 2026 | $2.91 | $2.99 | +2.8% |
| Apr 22, 2026 | $3.37 | $3.36 | -0.3% |
| Feb 4, 2026 | $2.74 | $2.77 | +1.0% |
| Oct 22, 2025 | $2.63 | $2.68 | +2.0% |
| Jul 23, 2025 | $2.92 | $2.96 | +1.4% |
| Apr 23, 2025 | $2.81 | $2.80 | -0.3% |
| Feb 12, 2025 | $2.45 | $2.52 | +3.0% |
Stocks like CME
| Name | Today | 1Y | Mkt cap | P/E | |
|---|---|---|---|---|---|
 SPGI S&P Global | -0.62% | -1% | $132.8B | 27.4x | Compare |
 ICE Intercontinental Exchange | -0.67% | +5% | $91.4B | 23.0x | Compare |
 MCO Moody's | -1.55% | +2% | $83.4B | 28.9x | Compare |
 NDAQ Nasdaq | -0.72% | +17% | $57.3B | 28.0x | Compare |
 MSCI MSCI | -0.74% | +16% | $44.8B | 31.7x | Compare |
 COIN Coinbase Global | -2.74% | -49% | $43.4B | — | Compare |
 CBOE Cboe Global Markets | +3.88% | +45% | $35.6B | 26.5x | Compare |
 FDS FactSet Research Systems | -1.23% | +18% | $11.8B | 22.7x | Compare |
CME news
- Bitcoin Cash vs Litecoin: Which Payment Coin Has More Upside in 2026? · Oct 23, 2026
- CME Crypto Derivatives Trading Volume Reaches $469.5B in Q3 · Oct 23, 2026
- Financial Exchanges CME, Cboe, ICE, Nasdaq Benefiting From Sector Rotation Out Of AI Stocks · Oct 22, 2026
- CME Group (CME) Stock Climbs On Record Q3 Earnings And Margin Strength · Oct 22, 2026
- CME Q3 deep dive: diversified volume growth and product innovation underpin results · Oct 22, 2026
CME stock FAQ
What is CME's market cap?
CME's market capitalization is $109.42 billion as of October 23, 2026, ranking 113th in the S&P 500.
What is CME's P/E ratio?
CME trades at a trailing price-to-earnings ratio of 25.1x and a forward P/E of 23.1x. Its median P/E over the period we track is 26.5x.
Does CME pay a dividend?
Yes. CME pays $5.20 per share a year, a 1.70% yield. It has raised its dividend 15 years in a row. Dividends grew 8.0% a year over the last five years.
How much has CME stock returned?
Including reinvested dividends, CME returned +18.1% over one year, +11.6% a year over five years, +15.7% a year over ten years through October 23, 2026.
Is CME stock overvalued?
At today's price, a reverse discounted cash flow model (10% discount rate, 3% terminal growth) implies CME must grow free cash flow about 18% a year for the next decade. Its free cash flow grew 11% a year over the last five years. Whether that is achievable decides if the stock is cheap or expensive. This is a model, not advice.
What is the CME price target?
16 analysts cover CME with an average 12-month price target of $316.00, +3% from the current price. 53% of them rate it a buy.
When does CME report earnings?
CME is expected to report earnings on February 3, 2027. It has beaten EPS estimates 2 quarters in a row.
How many employees does CME have?
CME has about 3,875 full-time employees, or $1.8 million of revenue per employee.
Sources: SEC EDGAR filings, Yahoo Finance market data (delayed), FI Handbook calculations. Last close October 23, 2026. Methodology